logo
Keysight Awarded NATO FORACS Contract to Enhance Operational Readiness

Keysight Awarded NATO FORACS Contract to Enhance Operational Readiness

Business Wire28-04-2025

AMSTERDAM--(BUSINESS WIRE)-- Keysight Technologies, Inc. (NYSE: KEYS) has been awarded a contract with NATO's Naval Forces Sensor and Weapons Accuracy Check Sites (FORACS) to modernize its testing capabilities for critical radar and electronic support measures (ESM) systems. Under this agreement, Keysight will deliver Radar Target Generator and Electronic Warfare testing (EW) solutions to be deployed at NATO Navy bases, enabling the calibration and maintenance of NATO radar systems and the assessment of ESM effectiveness.
Modern military and naval forces depend heavily on the accuracy and reliability of their radar and ESM systems for maintaining situational awareness, effective targeting, and timely threat detection. In an era of increasingly complex and rapidly evolving electronic warfare threats, defense organizations require sophisticated, high-fidelity test environments. These environments must be capable of replicating real-world scenarios with dynamic multi-emitter signals, advanced threat modeling, and closed-loop testing methodologies.
Keysight's Radar Target Generator and EW solutions are designed to meet these demanding requirements, empowering NATO FORACS to rigorously assess and optimize the operational readiness of radar and ESM systems across all member nations. The contract encompasses the integration and delivery of next-generation Radar Target Generators and EW threat simulators. This will ensure enhanced accuracy verification and thorough system performance testing within complex electromagnetic environments. Notably, the Radar Target Generator leverages commercial-off-the-shelf Keysight components, featuring customized firmware and a graphical user interface developed entirely in Europe and tailored to meet NATO's specific requirements.
The systems that Keysight will deliver to NATO is defined by several key factors, including:
High-fidelity radar target generation: Simulates precise radar returns, including Doppler shift, range, and cross-section variability, enabling accurate testing of radar tracking.
Sophisticated EW threat simulation: Creates complex electromagnetic threat environments with multi-emitter interference, jamming, and deceptive techniques to evaluate ESM system effectiveness.
Customizable, open-architecture design: The modular hardware and software framework allows for incremental system upgrades, ensuring adaptability to future mission requirements.
Deployable and modular configuration: Designed for field and lab deployment, providing flexible testing capability across multiple NATO sites.
The NATO FORACS Office in NATO Headquarters in Brussels, reported: 'The NATO FORACS Office is pleased to note the placement of this contract which will supply important equipment to restore NATO FORACS' core radar and ESM testing capabilities in order to meet its users' evolving demands.'
Thierry Locquette, EMEA VP and GM at Keysight, said:"NATO's ability to verify and enhance the accuracy of its radar and ESM systems is critical to mission success in today's contested electromagnetic spectrum environment. Keysight is proud to provide the cutting-edge solutions necessary to enable NATO FORACS to maintain the highest levels of sensor performance, ensuring operational superiority across allied forces. Our Radar Target Generator solution was developed in Europe, working closely with our local R&D and solution centers as well as with European technology partners to provide a highly realistic, flexible, and future-ready test capability for NATO's evolving defense needs."
Keysight will showcase its aerospace and defense capabilities at AOC Europe 2025, May 6-8. Visit Keysight at stand F21 to learn more.
About Keysight Technologies
At Keysight (NYSE: KEYS), we inspire and empower innovators to bring world-changing technologies to life. As an S&P 500 company, we're delivering market-leading design, emulation, and test solutions to help engineers develop and deploy faster, with less risk, throughout the entire product life cycle. We're a global innovation partner enabling customers in communications, industrial automation, aerospace and defense, automotive, semiconductor, and general electronics markets to accelerate innovation to connect and secure the world. Learn more at Keysight Newsroom and www.keysight.com.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Here's How You Can Earn $100 In Passive Income By Investing In Air Products And Chemicals Stock
Here's How You Can Earn $100 In Passive Income By Investing In Air Products And Chemicals Stock

Yahoo

time42 minutes ago

  • Yahoo

Here's How You Can Earn $100 In Passive Income By Investing In Air Products And Chemicals Stock

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Air Products and Chemicals Inc. (NYSE:APD) provides atmospheric gases, process and specialty gases, equipment, and related services globally. The 52-week range of Air Products and Chemicals stock price was $243.69 to $341.14. Air Products and Chemicals' dividend yield is 2.57%. It paid $7.16 per share in dividends during the last 12 months. Don't Miss: Invest Where It Hurts — And Help Millions Heal: Maximize saving for your retirement and cut down on taxes: . On May 1, the company announced its Q2 2025 earnings, posting revenues of $2.92 billion, missing the consensus estimate of $2.93 billion, as reported by Benzinga. Adjusted EPS fell 6% year-over-year to $2.69, missing the $2.83 consensus, as lower volumes and higher costs were partly offset by strong pricing. The company expects Q3 adjusted EPS of $2.90 to $3, compared to the consensus of $3.28. For full-year 2025, the adjusted EPS is expected to be between $11.85 and $12.15, lowered from the prior range of $12.70 to $13, and missing the consensus of $12.55. Check out this article by Benzinga for nine analysts' insights on Air Products and Chemicals. Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." If you want to make $100 per month — $1,200 annually — from Air Products dividends, your investment value needs to be approximately $46,693, which is around 168 shares at $278.70 each. Understanding the dividend yield calculations: When making an estimate, you need two key variables — the desired annual income ($1,200) and the dividend yield (2.57% in this case). So, $1,200 / 0.0257 = $46,693 to generate an income of $100 per month. You can calculate the dividend yield by dividing the annual dividend payments by the current price of the stock. The dividend yield can change over time. This is the outcome of fluctuating stock prices and dividend payments on a rolling instance, assume a stock that pays $2 as an annual dividend is priced at $50. Its dividend yield would be $2/$50 = 4%. If the stock price rises to $60, the dividend yield drops to 3.33% ($2/$60). A drop in stock price to $40 will have an inverse effect and increase the dividend yield to 5% ($2/$40). In summary, income-focused investors may find Air Products stock an attractive option for making a steady income of $100 per month by owning 168 shares of stock. There may be more upside to come as investors benefit from the company's consistent dividend hikes. Air Products and Chemicals has raised its dividend consecutively for the last 43 years. Lower interest rates mean some investments won't yield what they did in months past, but you don't have to lose those gains. Certain private market real estate investments are giving retail investors the opportunity to capitalize on these high-yield opportunities. , which provides access to a pool of short-term loans backed by residential real estate. The best part? Unlike other private credit funds, Looking for fractional real estate investment opportunities? The features the latest offerings. Image: Shutterstock This article Here's How You Can Earn $100 In Passive Income By Investing In Air Products And Chemicals Stock originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Bernstein Sticks to Its Buy Rating for Centene (CNC)
Bernstein Sticks to Its Buy Rating for Centene (CNC)

Business Insider

timean hour ago

  • Business Insider

Bernstein Sticks to Its Buy Rating for Centene (CNC)

Bernstein analyst Lance Wilkes maintained a Buy rating on Centene (CNC – Research Report) today and set a price target of $86.00. The company's shares closed today at $55.16. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Wilkes covers the Healthcare sector, focusing on stocks such as UnitedHealth, Humana, and Elevance Health. According to TipRanks, Wilkes has an average return of -0.3% and a 42.86% success rate on recommended stocks. In addition to Bernstein, Centene also received a Buy from Wells Fargo's Stephen Baxter in a report issued yesterday. However, on June 2, Barclays downgraded Centene (NYSE: CNC) to a Hold.

Molina Healthcare (MOH) Receives a Buy from Bernstein
Molina Healthcare (MOH) Receives a Buy from Bernstein

Business Insider

timean hour ago

  • Business Insider

Molina Healthcare (MOH) Receives a Buy from Bernstein

In a report released today, Lance Wilkes from Bernstein maintained a Buy rating on Molina Healthcare (MOH – Research Report), with a price target of $414.00. The company's shares closed today at $296.88. Confident Investing Starts Here: According to TipRanks, Wilkes is a 2-star analyst with an average return of -0.3% and a 42.86% success rate. Wilkes covers the Healthcare sector, focusing on stocks such as UnitedHealth, Humana, and Elevance Health. In addition to Bernstein, Molina Healthcare also received a Buy from Wells Fargo's Stephen Baxter in a report issued yesterday. However, on June 3, Barclays maintained a Hold rating on Molina Healthcare (NYSE: MOH). Based on Molina Healthcare's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $11.15 billion and a net profit of $298 million. In comparison, last year the company earned a revenue of $9.93 billion and had a net profit of $301 million Based on the recent corporate insider activity of 66 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MOH in relation to earlier this year. Last month, Dale Wolf, a Director at MOH sold 1,500.00 shares for a total of $484,328.00.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store